Protagonist Therapeutics, Inc. (PTGX)
94.48
+2.23
(+2.42%)
USD |
NASDAQ |
Dec 12, 15:19
Protagonist Therapeutics EPS Diluted (TTM): 0.6333 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 10.36 |
| ADMA Biologics, Inc. | 0.8515 |
| Regeneron Pharmaceuticals, Inc. | 41.77 |
| Vanda Pharmaceuticals, Inc. | -1.432 |
| Bristol Myers Squibb Co. | 2.962 |